Based on this observation, researchers at UCLA conducted the first trial of hormone therapy specifically targeted to MS, and found that estriol, an estrogen hormone that is produced during pregnancy, may be a treatment
for MS. In a preliminary study, the
hormone, given in a pill form, was found to reduce symptoms in a group of women with early MS. The hormone could eventually provide an alternative to injectible anti-inflammatory drugs used for MS.